Cellarity

About:

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Website: https://www.cellarity.com

Twitter/X: cellaritybio

Top Investors: BlackRock, The Baupost Group, Pictet Private Equity Investors S.A., Flagship Pioneering, Kyowa Kirin

Description:

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies. Its platform digitizes the molecular information in cells to elucidate how they behave in health and disease. Cellarity is using its platform to design medicines targeting the full cellular and molecular complexity of the disease, enabling a quantum leap in the success rate and speed of drug discovery.

Total Funding Amount:

$294M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Somerville, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

press(AT)cellarity.com

Founders:

Avak Kahvejian, Jim Collins, Nick Plugis, Noubar Afeyan

Number of Employees:

101-250

Last Funding Date:

2022-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai